Össur hf.: Össur hf: Share buyback program completed
Announcement no. 52/2019
9 September 2019
On 14 May 2019, Össur hf. initiated a share buy-back program, see
Company announcement no. 31/2019.
The purpose of the share buyback program was to reduce the Companys
share capital and adjust the capital structure by distributing
capital to shareholders in line with the Companys Capital Structure
and Dividend Policy. The program would end no later than 31 December
2019. The Company could purchase up to 5,000,000 shares under the
program, corresponding to 1.2% of the current share capital. The
total consideration for shares purchased under the program should not
exceed USD 10 million.
Following are the last transactions made under the program in week 17,
the period 2 September 2019 - 6 September 2019:
Date No. of Avg. purchase Transaction
shares price in DKK value in DKK
2 September 2019 21,000 47.87 1,005,299
3 September 2019 - - -
4 September 2019 13,514 48.32 653,033
5 September 2019 - - -
6 September 2019 - - -
Total 34,514 48.05 1,658,332
Össur acquired 1,621,079 shares under the program at the average price
of DKK 41.73. The total consideration amounted to around USD 10
million (approx. DKK 68 million) and thus the program has been
completed. Össur currently holds 2,338,397 own shares, corresponding
to 0.55% of the Companys total share capital.
The share buyback program was carried out in accordance with
Regulation No. 596/2014 of the European Parliament and of the Council
on market abuse (MAR), and the Commission delegated regulation No.
David Hreidarsson, Investor Relations, email@example.com, +354
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail please register
Össur (NASDAQ OMX: OSSR) is a global leader in non-invasive
orthopaedics that help people live a life without limitations. Its
business is focused on improving peoples mobility through the
delivery of innovative technologies within the fields of Prosthetics
and Bracing & Supports. A recognized Technology Pioneer, Össur
invests significantly in research and product development-its
award-winning designs ensuring a consistently strong position in the
market. Successful patient and clinical outcomes are further
empowered via Össurs educational programs and business solutions.
Headquartered in Iceland, Össur has major operations in the Americas,
Europe and Asia, with additional distributors worldwide.